Cargando…
Pathogenesis, Assessments, and Management of Chemotherapy-Related Cognitive Impairment (CRCI): An Updated Literature Review
There are various cancer treatments at present, and chemotherapy is one of the main methods. Chemotherapy-related cognitive impairment (CRCI), as one of the side effects of chemotherapy, has gradually attracted the attention of more and more researchers. CRCI has been verified by subjective reports...
Autores principales: | Lv, Longqin, Mao, Shanping, Dong, Huimin, Hu, Pan, Dong, Ruochen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7333028/ https://www.ncbi.nlm.nih.gov/pubmed/32684930 http://dx.doi.org/10.1155/2020/3942439 |
Ejemplares similares
-
Cognition Deficits in Parkinson's Disease: Mechanisms and Treatment
por: Fang, Congcong, et al.
Publicado: (2020) -
Managing Cancer and Living Meaningfully (CALM) alleviates chemotherapy related cognitive impairment (CRCI) in breast cancer survivors: A pilot study based on resting‐state fMRI
por: Yao, Senbang, et al.
Publicado: (2023) -
Psychological distress is involved in CRCI in breast cancer survivors via mediating cytokine levels
por: Pang, Lulian, et al.
Publicado: (2023) -
Pathology and pathogenesis of vascular cognitive impairment—a critical update
por: Jellinger, Kurt A.
Publicado: (2013) -
Expression of the sRNAs CrcZ and CrcY modulate the strength of carbon catabolite repression under diazotrophic or non-diazotrophic growing conditions in Azotobacter vinelandii
por: Martínez-Valenzuela, Marcela, et al.
Publicado: (2018)